Related Experiment Video
Updated: Jun 20, 2026

Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures
Published on: July 12, 2024
Management of symptomatic Meesmann dystrophy
Isabelle Jalbert1, Fiona Stapleton
1School of Optometry and Vision Science, University of New South Wales and Institute for Eye Research, Sydney, NSW 2052, Australia. i.jalbert@unsw.edu.au
Abstract:
Meesmann dystrophy is a non-progressive autosomal dominant corneal epithelial dystrophy characterized by intraepithelial cysts, which is likely to be caused by an intraepithelial metabolic abnormality. Cases may be asymptomatic or be associated with symptoms of irritation, lacrimation, and photophobia. Palliative treatment includes ocular lubricants, cycloplegia, and therapeutic contact lenses. In severe cases, management with epithelial debridement, phototherapeutic keratectomy, and lamellar keratoplasty has been advocated. Most recently, the genetic and molecular basis of Meesmann dystrophy have been explored, and mutations in the genes encoding corneal epithelial keratins have been reported. This report describes a case of Meesmann dystrophy with unusually severe symptoms and punctate epithelial keratopathy managed with a therapeutic contact lens.
Related Concept Videos
Mitral Stenosis III: Medical Management
Myocarditis III: Medical Management
Cardiomyopathy V: Interprofessional Care
Mitral Stenosis IV: Nursing Management
Rheumatic Heart Disease III: Medical Management
Mitral Regurgitation III: Medical Management

